Global Blood Plasma Fractionation Technology Supply, Demand and Key Producers, 2024-2030

Description

Human blood plasma is nature's raw material for dozens of life-saving treatments and medications. By extracting the active ingredients and disinfection, people get related preparations from blood plasma, which is called Plasma Fractionation Technology. In this report, we mainly study the Plasma Fractionation Technology products, such as: Immune Globulin, Coagulation Factor, Albumin, etc.

The global Blood Plasma Fractionation Technology market size is expected to reach $ 55550 million by 2030, rising at a market growth of 7.3% CAGR during the forecast period (2024-2030).

Market Drivers:
Increasing Demand for Plasma-Derived Therapies: The rising prevalence of chronic diseases, such as immune deficiencies, hemophilia, and autoimmune disorders, has led to increased demand for plasma-derived products like immunoglobulins, clotting factors, and albumin, driving the Plasma Fractionation Technology market.

Aging Population: The global aging population is more prone to chronic diseases and conditions requiring plasma-derived therapies, contributing to the growth of the Plasma Fractionation Technologyation market.

Growing Use of Immunoglobulins: Immunoglobulins are increasingly used in the treatment of a wide range of diseases, including primary and secondary immune deficiencies, boosting the need for Plasma Fractionation Technology to produce these therapies.

Rising Healthcare Expenditure and Improved Healthcare Access: Expanding healthcare infrastructure in developing countries, combined with rising healthcare expenditure, is driving demand for advanced medical treatments and plasma-derived products.

Market Challenges:
High Costs of Plasma-Derived Products: The complex and time-consuming process of Plasma Fractionation Technologyation leads to high costs for plasma-derived products, making these treatments less accessible, particularly in low-income regions.

Limited Plasma Supply: The availability of plasma for fractionation is often limited by low donation rates, regulatory restrictions, and the lengthy process of screening and collecting plasma, leading to supply shortages.

Stringent Regulatory Framework: Plasma Fractionation Technologyation is subject to rigorous regulatory requirements to ensure safety and efficacy. Meeting these regulations can increase development costs and slow the introduction of new products to the market.

Complex Manufacturing Process: The Plasma Fractionation Technologyation process is technically challenging and requires significant investment in infrastructure, equipment, and skilled labor, posing barriers for new entrants and smaller manufacturers.

The outbreak of COVID-19 pandemic has led to decrease in number of blood donations and plasma collections, which hampers the market growth as it leads to shortage in raw material supply.

The classification of Plasma Fractionation Technology includes Immune Globulin, Coagulation Factor, Albumin and Other. In 2023, Immune Globulin accounted for a share of 51% in the global Plasma Fractionation Technology market.

North America is the largest consumption place, with a revenue market share nearly 40 % in 2023. Following North America, Europe is the second largest consumption place with the revenue market share of 24 %; China is also an important sales region for the Plasma Fractionation Technology.

This report studies the global Blood Plasma Fractionation Technology demand, key companies, and key regions.

This report is a detailed and comprehensive analysis of the world market for Blood Plasma Fractionation Technology, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2023 as the base year. This report explores demand trends and competition, as well as details the characteristics of Blood Plasma Fractionation Technology that contribute to its increasing demand across many markets.

Highlights and key features of the study
Global Blood Plasma Fractionation Technology total market, 2019-2030, (USD Million)
Global Blood Plasma Fractionation Technology total market by region & country, CAGR, 2019-2030, (USD Million)
U.S. VS China: Blood Plasma Fractionation Technology total market, key domestic companies, and share, (USD Million)
Global Blood Plasma Fractionation Technology revenue by player, revenue and market share 2019-2024, (USD Million)
Global Blood Plasma Fractionation Technology total market by Type, CAGR, 2019-2030, (USD Million)
Global Blood Plasma Fractionation Technology total market by Application, CAGR, 2019-2030, (USD Million)
This report profiles major players in the global Blood Plasma Fractionation Technology market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Takeda, CSL, Grifols, Octapharma, Kedrion, LFB Group, Biotest, BPL, RAAS, CBPO, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the world Blood Plasma Fractionation Technology market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2019-2030 by year with 2023 as the base year, 2024 as the estimate year, and 2025-2030 as the forecast year.

Global Blood Plasma Fractionation Technology Market, By Region:
    United States
    China
    Europe
    Japan
    South Korea
    ASEAN
    India
    Rest of World

Global Blood Plasma Fractionation Technology Market, Segmentation by Type
    Albumin
    Immune Globulin
    Coagulation Factor
    Others

Global Blood Plasma Fractionation Technology Market, Segmentation by Application:
    Hospital
    Retail Pharmacy
    Others

Companies Profiled:
    Takeda
    CSL
    Grifols
    Octapharma
    Kedrion
    LFB Group
    Biotest
    BPL
    RAAS
    CBPO
    Hualan Bio
    Tiantan Bio
    Shuanglin Bio
    Boya Bio
    Yuanda Shuyang
    Weiguang Bio
    Nanyue Bio
    KM Biologics

Key Questions Answered
1. How big is the global Blood Plasma Fractionation Technology market?
2. What is the demand of the global Blood Plasma Fractionation Technology market?
3. What is the year over year growth of the global Blood Plasma Fractionation Technology market?
4. What is the total value of the global Blood Plasma Fractionation Technology market?
5. Who are the Major Players in the global Blood Plasma Fractionation Technology market?
6. What are the growth factors driving the market demand?

Table of Contents

1 Supply Summary
    1.1 Blood Plasma Fractionation Technology Introduction
    1.2 World Blood Plasma Fractionation Technology Market Size & Forecast (2019 & 2023 & 2030)
    1.3 World Blood Plasma Fractionation Technology Total Market by Region (by Headquarter Location)
        1.3.1 World Blood Plasma Fractionation Technology Market Size by Region (2019-2030), (by Headquarter Location)
        1.3.2 United States Based Company Blood Plasma Fractionation Technology Revenue (2019-2030)
        1.3.3 China Based Company Blood Plasma Fractionation Technology Revenue (2019-2030)
        1.3.4 Europe Based Company Blood Plasma Fractionation Technology Revenue (2019-2030)
        1.3.5 Japan Based Company Blood Plasma Fractionation Technology Revenue (2019-2030)
        1.3.6 South Korea Based Company Blood Plasma Fractionation Technology Revenue (2019-2030)
        1.3.7 ASEAN Based Company Blood Plasma Fractionation Technology Revenue (2019-2030)
        1.3.8 India Based Company Blood Plasma Fractionation Technology Revenue (2019-2030)
    1.4 Market Drivers, Restraints and Trends
        1.4.1 Blood Plasma Fractionation Technology Market Drivers
        1.4.2 Factors Affecting Demand
        1.4.3 Major Market Trends

2 Demand Summary
    2.1 World Blood Plasma Fractionation Technology Consumption Value (2019-2030)
    2.2 World Blood Plasma Fractionation Technology Consumption Value by Region
        2.2.1 World Blood Plasma Fractionation Technology Consumption Value by Region (2019-2024)
        2.2.2 World Blood Plasma Fractionation Technology Consumption Value Forecast by Region (2025-2030)
    2.3 United States Blood Plasma Fractionation Technology Consumption Value (2019-2030)
    2.4 China Blood Plasma Fractionation Technology Consumption Value (2019-2030)
    2.5 Europe Blood Plasma Fractionation Technology Consumption Value (2019-2030)
    2.6 Japan Blood Plasma Fractionation Technology Consumption Value (2019-2030)
    2.7 South Korea Blood Plasma Fractionation Technology Consumption Value (2019-2030)
    2.8 ASEAN Blood Plasma Fractionation Technology Consumption Value (2019-2030)
    2.9 India Blood Plasma Fractionation Technology Consumption Value (2019-2030)

3 World Blood Plasma Fractionation Technology Companies Competitive Analysis
    3.1 World Blood Plasma Fractionation Technology Revenue by Player (2019-2024)
    3.2 Industry Rank and Concentration Rate (CR)
        3.2.1 Global Blood Plasma Fractionation Technology Industry Rank of Major Players
        3.2.2 Global Concentration Ratios (CR4) for Blood Plasma Fractionation Technology in 2023
        3.2.3 Global Concentration Ratios (CR8) for Blood Plasma Fractionation Technology in 2023
    3.3 Blood Plasma Fractionation Technology Company Evaluation Quadrant
    3.4 Blood Plasma Fractionation Technology Market: Overall Company Footprint Analysis
        3.4.1 Blood Plasma Fractionation Technology Market: Region Footprint
        3.4.2 Blood Plasma Fractionation Technology Market: Company Product Type Footprint
        3.4.3 Blood Plasma Fractionation Technology Market: Company Product Application Footprint
    3.5 Competitive Environment
        3.5.1 Historical Structure of the Industry
        3.5.2 Barriers of Market Entry
        3.5.3 Factors of Competition
    3.6 Mergers & Acquisitions Activity

4 United States VS China VS Rest of World (by Headquarter Location)
    4.1 United States VS China: Blood Plasma Fractionation Technology Revenue Comparison (by Headquarter Location)
        4.1.1 United States VS China: Blood Plasma Fractionation Technology Revenue Comparison (2019 & 2023 & 2030) (by Headquarter Location)
        4.1.2 United States VS China: Blood Plasma Fractionation Technology Revenue Market Share Comparison (2019 & 2023 & 2030)
    4.2 United States Based Companies VS China Based Companies: Blood Plasma Fractionation Technology Consumption Value Comparison
        4.2.1 United States VS China: Blood Plasma Fractionation Technology Consumption Value Comparison (2019 & 2023 & 2030)
        4.2.2 United States VS China: Blood Plasma Fractionation Technology Consumption Value Market Share Comparison (2019 & 2023 & 2030)
    4.3 United States Based Blood Plasma Fractionation Technology Companies and Market Share, 2019-2024
        4.3.1 United States Based Blood Plasma Fractionation Technology Companies, Headquarters (States, Country)
        4.3.2 United States Based Companies Blood Plasma Fractionation Technology Revenue, (2019-2024)
    4.4 China Based Companies Blood Plasma Fractionation Technology Revenue and Market Share, 2019-2024
        4.4.1 China Based Blood Plasma Fractionation Technology Companies, Company Headquarters (Province, Country)
        4.4.2 China Based Companies Blood Plasma Fractionation Technology Revenue, (2019-2024)
    4.5 Rest of World Based Blood Plasma Fractionation Technology Companies and Market Share, 2019-2024
        4.5.1 Rest of World Based Blood Plasma Fractionation Technology Companies, Headquarters (Province, Country)
        4.5.2 Rest of World Based Companies Blood Plasma Fractionation Technology Revenue (2019-2024)

5 Market Analysis by Type
    5.1 World Blood Plasma Fractionation Technology Market Size Overview by Type: 2019 VS 2023 VS 2030
    5.2 Segment Introduction by Type
        5.2.1 Albumin
        5.2.2 Immune Globulin
        5.2.3 Coagulation Factor
        5.2.4 Others
    5.3 Market Segment by Type
        5.3.1 World Blood Plasma Fractionation Technology Market Size by Type (2019-2024)
        5.3.2 World Blood Plasma Fractionation Technology Market Size by Type (2025-2030)
        5.3.3 World Blood Plasma Fractionation Technology Market Size Market Share by Type (2025-2030)

6 Market Analysis by Application
    6.1 World Blood Plasma Fractionation Technology Market Size Overview by Application: 2019 VS 2023 VS 2030
    6.2 Segment Introduction by Application
        6.2.1 Hospital
        6.2.2 Retail Pharmacy
        6.2.3 Others
    6.3 Market Segment by Application
        6.3.1 World Blood Plasma Fractionation Technology Market Size by Application (2019-2024)
        6.3.2 World Blood Plasma Fractionation Technology Market Size by Application (2025-2030)
        6.3.3 World Blood Plasma Fractionation Technology Market Size Market Share by Application (2019-2030)

7 Company Profiles
    7.1 Takeda
        7.1.1 Takeda Details
        7.1.2 Takeda Major Business
        7.1.3 Takeda Blood Plasma Fractionation Technology Product and Services
        7.1.4 Takeda Blood Plasma Fractionation Technology Revenue, Gross Margin and Market Share (2019-2024)
        7.1.5 Takeda Recent Developments/Updates
        7.1.6 Takeda Competitive Strengths & Weaknesses
    7.2 CSL
        7.2.1 CSL Details
        7.2.2 CSL Major Business
        7.2.3 CSL Blood Plasma Fractionation Technology Product and Services
        7.2.4 CSL Blood Plasma Fractionation Technology Revenue, Gross Margin and Market Share (2019-2024)
        7.2.5 CSL Recent Developments/Updates
        7.2.6 CSL Competitive Strengths & Weaknesses
    7.3 Grifols
        7.3.1 Grifols Details
        7.3.2 Grifols Major Business
        7.3.3 Grifols Blood Plasma Fractionation Technology Product and Services
        7.3.4 Grifols Blood Plasma Fractionation Technology Revenue, Gross Margin and Market Share (2019-2024)
        7.3.5 Grifols Recent Developments/Updates
        7.3.6 Grifols Competitive Strengths & Weaknesses
    7.4 Octapharma
        7.4.1 Octapharma Details
        7.4.2 Octapharma Major Business
        7.4.3 Octapharma Blood Plasma Fractionation Technology Product and Services
        7.4.4 Octapharma Blood Plasma Fractionation Technology Revenue, Gross Margin and Market Share (2019-2024)
        7.4.5 Octapharma Recent Developments/Updates
        7.4.6 Octapharma Competitive Strengths & Weaknesses
    7.5 Kedrion
        7.5.1 Kedrion Details
        7.5.2 Kedrion Major Business
        7.5.3 Kedrion Blood Plasma Fractionation Technology Product and Services
        7.5.4 Kedrion Blood Plasma Fractionation Technology Revenue, Gross Margin and Market Share (2019-2024)
        7.5.5 Kedrion Recent Developments/Updates
        7.5.6 Kedrion Competitive Strengths & Weaknesses
    7.6 LFB Group
        7.6.1 LFB Group Details
        7.6.2 LFB Group Major Business
        7.6.3 LFB Group Blood Plasma Fractionation Technology Product and Services
        7.6.4 LFB Group Blood Plasma Fractionation Technology Revenue, Gross Margin and Market Share (2019-2024)
        7.6.5 LFB Group Recent Developments/Updates
        7.6.6 LFB Group Competitive Strengths & Weaknesses
    7.7 Biotest
        7.7.1 Biotest Details
        7.7.2 Biotest Major Business
        7.7.3 Biotest Blood Plasma Fractionation Technology Product and Services
        7.7.4 Biotest Blood Plasma Fractionation Technology Revenue, Gross Margin and Market Share (2019-2024)
        7.7.5 Biotest Recent Developments/Updates
        7.7.6 Biotest Competitive Strengths & Weaknesses
    7.8 BPL
        7.8.1 BPL Details
        7.8.2 BPL Major Business
        7.8.3 BPL Blood Plasma Fractionation Technology Product and Services
        7.8.4 BPL Blood Plasma Fractionation Technology Revenue, Gross Margin and Market Share (2019-2024)
        7.8.5 BPL Recent Developments/Updates
        7.8.6 BPL Competitive Strengths & Weaknesses
    7.9 RAAS
        7.9.1 RAAS Details
        7.9.2 RAAS Major Business
        7.9.3 RAAS Blood Plasma Fractionation Technology Product and Services
        7.9.4 RAAS Blood Plasma Fractionation Technology Revenue, Gross Margin and Market Share (2019-2024)
        7.9.5 RAAS Recent Developments/Updates
        7.9.6 RAAS Competitive Strengths & Weaknesses
    7.10 CBPO
        7.10.1 CBPO Details
        7.10.2 CBPO Major Business
        7.10.3 CBPO Blood Plasma Fractionation Technology Product and Services
        7.10.4 CBPO Blood Plasma Fractionation Technology Revenue, Gross Margin and Market Share (2019-2024)
        7.10.5 CBPO Recent Developments/Updates
        7.10.6 CBPO Competitive Strengths & Weaknesses
    7.11 Hualan Bio
        7.11.1 Hualan Bio Details
        7.11.2 Hualan Bio Major Business
        7.11.3 Hualan Bio Blood Plasma Fractionation Technology Product and Services
        7.11.4 Hualan Bio Blood Plasma Fractionation Technology Revenue, Gross Margin and Market Share (2019-2024)
        7.11.5 Hualan Bio Recent Developments/Updates
        7.11.6 Hualan Bio Competitive Strengths & Weaknesses
    7.12 Tiantan Bio
        7.12.1 Tiantan Bio Details
        7.12.2 Tiantan Bio Major Business
        7.12.3 Tiantan Bio Blood Plasma Fractionation Technology Product and Services
        7.12.4 Tiantan Bio Blood Plasma Fractionation Technology Revenue, Gross Margin and Market Share (2019-2024)
        7.12.5 Tiantan Bio Recent Developments/Updates
        7.12.6 Tiantan Bio Competitive Strengths & Weaknesses
    7.13 Shuanglin Bio
        7.13.1 Shuanglin Bio Details
        7.13.2 Shuanglin Bio Major Business
        7.13.3 Shuanglin Bio Blood Plasma Fractionation Technology Product and Services
        7.13.4 Shuanglin Bio Blood Plasma Fractionation Technology Revenue, Gross Margin and Market Share (2019-2024)
        7.13.5 Shuanglin Bio Recent Developments/Updates
        7.13.6 Shuanglin Bio Competitive Strengths & Weaknesses
    7.14 Boya Bio
        7.14.1 Boya Bio Details
        7.14.2 Boya Bio Major Business
        7.14.3 Boya Bio Blood Plasma Fractionation Technology Product and Services
        7.14.4 Boya Bio Blood Plasma Fractionation Technology Revenue, Gross Margin and Market Share (2019-2024)
        7.14.5 Boya Bio Recent Developments/Updates
        7.14.6 Boya Bio Competitive Strengths & Weaknesses
    7.15 Yuanda Shuyang
        7.15.1 Yuanda Shuyang Details
        7.15.2 Yuanda Shuyang Major Business
        7.15.3 Yuanda Shuyang Blood Plasma Fractionation Technology Product and Services
        7.15.4 Yuanda Shuyang Blood Plasma Fractionation Technology Revenue, Gross Margin and Market Share (2019-2024)
        7.15.5 Yuanda Shuyang Recent Developments/Updates
        7.15.6 Yuanda Shuyang Competitive Strengths & Weaknesses
    7.16 Weiguang Bio
        7.16.1 Weiguang Bio Details
        7.16.2 Weiguang Bio Major Business
        7.16.3 Weiguang Bio Blood Plasma Fractionation Technology Product and Services
        7.16.4 Weiguang Bio Blood Plasma Fractionation Technology Revenue, Gross Margin and Market Share (2019-2024)
        7.16.5 Weiguang Bio Recent Developments/Updates
        7.16.6 Weiguang Bio Competitive Strengths & Weaknesses
    7.17 Nanyue Bio
        7.17.1 Nanyue Bio Details
        7.17.2 Nanyue Bio Major Business
        7.17.3 Nanyue Bio Blood Plasma Fractionation Technology Product and Services
        7.17.4 Nanyue Bio Blood Plasma Fractionation Technology Revenue, Gross Margin and Market Share (2019-2024)
        7.17.5 Nanyue Bio Recent Developments/Updates
        7.17.6 Nanyue Bio Competitive Strengths & Weaknesses
    7.18 KM Biologics
        7.18.1 KM Biologics Details
        7.18.2 KM Biologics Major Business
        7.18.3 KM Biologics Blood Plasma Fractionation Technology Product and Services
        7.18.4 KM Biologics Blood Plasma Fractionation Technology Revenue, Gross Margin and Market Share (2019-2024)
        7.18.5 KM Biologics Recent Developments/Updates
        7.18.6 KM Biologics Competitive Strengths & Weaknesses

8 Industry Chain Analysis
    8.1 Blood Plasma Fractionation Technology Industry Chain
    8.2 Blood Plasma Fractionation Technology Upstream Analysis
    8.3 Blood Plasma Fractionation Technology Midstream Analysis
    8.4 Blood Plasma Fractionation Technology Downstream Analysis

9 Research Findings and Conclusion

10 Appendix
    10.1 Methodology
    10.2 Research Process and Data Source
    10.3 Disclaimer

Table of Figures

List of Tables
 Table 1. World Blood Plasma Fractionation Technology Revenue by Region (2019, 2023 and 2030) & (USD Million), (by Headquarter Location)
 Table 2. World Blood Plasma Fractionation Technology Revenue by Region (2019-2024) & (USD Million), (by Headquarter Location)
 Table 3. World Blood Plasma Fractionation Technology Revenue by Region (2025-2030) & (USD Million), (by Headquarter Location)
 Table 4. World Blood Plasma Fractionation Technology Revenue Market Share by Region (2019-2024), (by Headquarter Location)
 Table 5. World Blood Plasma Fractionation Technology Revenue Market Share by Region (2025-2030), (by Headquarter Location)
 Table 6. Major Market Trends
 Table 7. World Blood Plasma Fractionation Technology Consumption Value Growth Rate Forecast by Region (2019 & 2023 & 2030) & (USD Million)
 Table 8. World Blood Plasma Fractionation Technology Consumption Value by Region (2019-2024) & (USD Million)
 Table 9. World Blood Plasma Fractionation Technology Consumption Value Forecast by Region (2025-2030) & (USD Million)
 Table 10. World Blood Plasma Fractionation Technology Revenue by Player (2019-2024) & (USD Million)
 Table 11. Revenue Market Share of Key Blood Plasma Fractionation Technology Players in 2023
 Table 12. World Blood Plasma Fractionation Technology Industry Rank of Major Player, Based on Revenue in 2023
 Table 13. Global Blood Plasma Fractionation Technology Company Evaluation Quadrant
 Table 14. Head Office of Key Blood Plasma Fractionation Technology Players
 Table 15. Blood Plasma Fractionation Technology Market: Company Product Type Footprint
 Table 16. Blood Plasma Fractionation Technology Market: Company Product Application Footprint
 Table 17. Blood Plasma Fractionation Technology Mergers & Acquisitions Activity
 Table 18. United States VS China Blood Plasma Fractionation Technology Revenue Comparison, (2019 & 2023 & 2030) & (USD Million)
 Table 19. United States VS China Blood Plasma Fractionation Technology Consumption Value Comparison, (2019 & 2023 & 2030) & (USD Million)
 Table 20. United States Based Blood Plasma Fractionation Technology Companies, Headquarters (States, Country)
 Table 21. United States Based Companies Blood Plasma Fractionation Technology Revenue, (2019-2024) & (USD Million)
 Table 22. United States Based Companies Blood Plasma Fractionation Technology Revenue Market Share (2019-2024)
 Table 23. China Based Blood Plasma Fractionation Technology Companies, Headquarters (Province, Country)
 Table 24. China Based Companies Blood Plasma Fractionation Technology Revenue, (2019-2024) & (USD Million)
 Table 25. China Based Companies Blood Plasma Fractionation Technology Revenue Market Share (2019-2024)
 Table 26. Rest of World Based Blood Plasma Fractionation Technology Companies, Headquarters (Province, Country)
 Table 27. Rest of World Based Companies Blood Plasma Fractionation Technology Revenue (2019-2024) & (USD Million)
 Table 28. Rest of World Based Companies Blood Plasma Fractionation Technology Revenue Market Share (2019-2024)
 Table 29. World Blood Plasma Fractionation Technology Market Size by Type, (USD Million), 2019 & 2023 & 2030
 Table 30. World Blood Plasma Fractionation Technology Market Size Value by Type (2019-2024) & (USD Million)
 Table 31. World Blood Plasma Fractionation Technology Market Size by Type (2025-2030) & (USD Million)
 Table 32. World Blood Plasma Fractionation Technology Market Size by Application, (USD Million), 2019 & 2023 & 2030
 Table 33. World Blood Plasma Fractionation Technology Market Size by Application (2019-2024) & (USD Million)
 Table 34. World Blood Plasma Fractionation Technology Market Size by Application (2025-2030) & (USD Million)
 Table 35. Takeda Basic Information, Manufacturing Base and Competitors
 Table 36. Takeda Major Business
 Table 37. Takeda Blood Plasma Fractionation Technology Product and Services
 Table 38. Takeda Blood Plasma Fractionation Technology Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
 Table 39. Takeda Recent Developments/Updates
 Table 40. Takeda Competitive Strengths & Weaknesses
 Table 41. CSL Basic Information, Manufacturing Base and Competitors
 Table 42. CSL Major Business
 Table 43. CSL Blood Plasma Fractionation Technology Product and Services
 Table 44. CSL Blood Plasma Fractionation Technology Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
 Table 45. CSL Recent Developments/Updates
 Table 46. CSL Competitive Strengths & Weaknesses
 Table 47. Grifols Basic Information, Manufacturing Base and Competitors
 Table 48. Grifols Major Business
 Table 49. Grifols Blood Plasma Fractionation Technology Product and Services
 Table 50. Grifols Blood Plasma Fractionation Technology Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
 Table 51. Grifols Recent Developments/Updates
 Table 52. Grifols Competitive Strengths & Weaknesses
 Table 53. Octapharma Basic Information, Manufacturing Base and Competitors
 Table 54. Octapharma Major Business
 Table 55. Octapharma Blood Plasma Fractionation Technology Product and Services
 Table 56. Octapharma Blood Plasma Fractionation Technology Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
 Table 57. Octapharma Recent Developments/Updates
 Table 58. Octapharma Competitive Strengths & Weaknesses
 Table 59. Kedrion Basic Information, Manufacturing Base and Competitors
 Table 60. Kedrion Major Business
 Table 61. Kedrion Blood Plasma Fractionation Technology Product and Services
 Table 62. Kedrion Blood Plasma Fractionation Technology Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
 Table 63. Kedrion Recent Developments/Updates
 Table 64. Kedrion Competitive Strengths & Weaknesses
 Table 65. LFB Group Basic Information, Manufacturing Base and Competitors
 Table 66. LFB Group Major Business
 Table 67. LFB Group Blood Plasma Fractionation Technology Product and Services
 Table 68. LFB Group Blood Plasma Fractionation Technology Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
 Table 69. LFB Group Recent Developments/Updates
 Table 70. LFB Group Competitive Strengths & Weaknesses
 Table 71. Biotest Basic Information, Manufacturing Base and Competitors
 Table 72. Biotest Major Business
 Table 73. Biotest Blood Plasma Fractionation Technology Product and Services
 Table 74. Biotest Blood Plasma Fractionation Technology Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
 Table 75. Biotest Recent Developments/Updates
 Table 76. Biotest Competitive Strengths & Weaknesses
 Table 77. BPL Basic Information, Manufacturing Base and Competitors
 Table 78. BPL Major Business
 Table 79. BPL Blood Plasma Fractionation Technology Product and Services
 Table 80. BPL Blood Plasma Fractionation Technology Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
 Table 81. BPL Recent Developments/Updates
 Table 82. BPL Competitive Strengths & Weaknesses
 Table 83. RAAS Basic Information, Manufacturing Base and Competitors
 Table 84. RAAS Major Business
 Table 85. RAAS Blood Plasma Fractionation Technology Product and Services
 Table 86. RAAS Blood Plasma Fractionation Technology Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
 Table 87. RAAS Recent Developments/Updates
 Table 88. RAAS Competitive Strengths & Weaknesses
 Table 89. CBPO Basic Information, Manufacturing Base and Competitors
 Table 90. CBPO Major Business
 Table 91. CBPO Blood Plasma Fractionation Technology Product and Services
 Table 92. CBPO Blood Plasma Fractionation Technology Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
 Table 93. CBPO Recent Developments/Updates
 Table 94. CBPO Competitive Strengths & Weaknesses
 Table 95. Hualan Bio Basic Information, Manufacturing Base and Competitors
 Table 96. Hualan Bio Major Business
 Table 97. Hualan Bio Blood Plasma Fractionation Technology Product and Services
 Table 98. Hualan Bio Blood Plasma Fractionation Technology Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
 Table 99. Hualan Bio Recent Developments/Updates
 Table 100. Hualan Bio Competitive Strengths & Weaknesses
 Table 101. Tiantan Bio Basic Information, Manufacturing Base and Competitors
 Table 102. Tiantan Bio Major Business
 Table 103. Tiantan Bio Blood Plasma Fractionation Technology Product and Services
 Table 104. Tiantan Bio Blood Plasma Fractionation Technology Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
 Table 105. Tiantan Bio Recent Developments/Updates
 Table 106. Tiantan Bio Competitive Strengths & Weaknesses
 Table 107. Shuanglin Bio Basic Information, Manufacturing Base and Competitors
 Table 108. Shuanglin Bio Major Business
 Table 109. Shuanglin Bio Blood Plasma Fractionation Technology Product and Services
 Table 110. Shuanglin Bio Blood Plasma Fractionation Technology Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
 Table 111. Shuanglin Bio Recent Developments/Updates
 Table 112. Shuanglin Bio Competitive Strengths & Weaknesses
 Table 113. Boya Bio Basic Information, Manufacturing Base and Competitors
 Table 114. Boya Bio Major Business
 Table 115. Boya Bio Blood Plasma Fractionation Technology Product and Services
 Table 116. Boya Bio Blood Plasma Fractionation Technology Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
 Table 117. Boya Bio Recent Developments/Updates
 Table 118. Boya Bio Competitive Strengths & Weaknesses
 Table 119. Yuanda Shuyang Basic Information, Manufacturing Base and Competitors
 Table 120. Yuanda Shuyang Major Business
 Table 121. Yuanda Shuyang Blood Plasma Fractionation Technology Product and Services
 Table 122. Yuanda Shuyang Blood Plasma Fractionation Technology Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
 Table 123. Yuanda Shuyang Recent Developments/Updates
 Table 124. Yuanda Shuyang Competitive Strengths & Weaknesses
 Table 125. Weiguang Bio Basic Information, Manufacturing Base and Competitors
 Table 126. Weiguang Bio Major Business
 Table 127. Weiguang Bio Blood Plasma Fractionation Technology Product and Services
 Table 128. Weiguang Bio Blood Plasma Fractionation Technology Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
 Table 129. Weiguang Bio Recent Developments/Updates
 Table 130. Weiguang Bio Competitive Strengths & Weaknesses
 Table 131. Nanyue Bio Basic Information, Manufacturing Base and Competitors
 Table 132. Nanyue Bio Major Business
 Table 133. Nanyue Bio Blood Plasma Fractionation Technology Product and Services
 Table 134. Nanyue Bio Blood Plasma Fractionation Technology Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
 Table 135. Nanyue Bio Recent Developments/Updates
 Table 136. Nanyue Bio Competitive Strengths & Weaknesses
 Table 137. KM Biologics Basic Information, Manufacturing Base and Competitors
 Table 138. KM Biologics Major Business
 Table 139. KM Biologics Blood Plasma Fractionation Technology Product and Services
 Table 140. KM Biologics Blood Plasma Fractionation Technology Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
 Table 141. KM Biologics Recent Developments/Updates
 Table 142. KM Biologics Competitive Strengths & Weaknesses
 Table 143. Global Key Players of Blood Plasma Fractionation Technology Upstream (Raw Materials)
 Table 144. Global Blood Plasma Fractionation Technology Typical Customers


List of Figures
 Figure 1. Blood Plasma Fractionation Technology Picture
 Figure 2. World Blood Plasma Fractionation Technology Total Revenue: 2019 & 2023 & 2030, (USD Million)
 Figure 3. World Blood Plasma Fractionation Technology Total Revenue (2019-2030) & (USD Million)
 Figure 4. World Blood Plasma Fractionation Technology Revenue by Region (2019, 2023 and 2030) & (USD Million), (by Headquarter Location)
 Figure 5. World Blood Plasma Fractionation Technology Revenue Market Share by Region (2019-2030), (by Headquarter Location)
 Figure 6. United States Based Company Blood Plasma Fractionation Technology Revenue (2019-2030) & (USD Million)
 Figure 7. China Based Company Blood Plasma Fractionation Technology Revenue (2019-2030) & (USD Million)
 Figure 8. Europe Based Company Blood Plasma Fractionation Technology Revenue (2019-2030) & (USD Million)
 Figure 9. Japan Based Company Blood Plasma Fractionation Technology Revenue (2019-2030) & (USD Million)
 Figure 10. South Korea Based Company Blood Plasma Fractionation Technology Revenue (2019-2030) & (USD Million)
 Figure 11. ASEAN Based Company Blood Plasma Fractionation Technology Revenue (2019-2030) & (USD Million)
 Figure 12. India Based Company Blood Plasma Fractionation Technology Revenue (2019-2030) & (USD Million)
 Figure 13. Blood Plasma Fractionation Technology Market Drivers
 Figure 14. Factors Affecting Demand
 Figure 15. World Blood Plasma Fractionation Technology Consumption Value (2019-2030) & (USD Million)
 Figure 16. World Blood Plasma Fractionation Technology Consumption Value Market Share by Region (2019-2030)
 Figure 17. United States Blood Plasma Fractionation Technology Consumption Value (2019-2030) & (USD Million)
 Figure 18. China Blood Plasma Fractionation Technology Consumption Value (2019-2030) & (USD Million)
 Figure 19. Europe Blood Plasma Fractionation Technology Consumption Value (2019-2030) & (USD Million)
 Figure 20. Japan Blood Plasma Fractionation Technology Consumption Value (2019-2030) & (USD Million)
 Figure 21. South Korea Blood Plasma Fractionation Technology Consumption Value (2019-2030) & (USD Million)
 Figure 22. ASEAN Blood Plasma Fractionation Technology Consumption Value (2019-2030) & (USD Million)
 Figure 23. India Blood Plasma Fractionation Technology Consumption Value (2019-2030) & (USD Million)
 Figure 24. Producer Shipments of Blood Plasma Fractionation Technology by Player Revenue ($MM) and Market Share (%): 2023
 Figure 25. Global Four-firm Concentration Ratios (CR4) for Blood Plasma Fractionation Technology Markets in 2023
 Figure 26. Global Four-firm Concentration Ratios (CR8) for Blood Plasma Fractionation Technology Markets in 2023
 Figure 27. United States VS China: Blood Plasma Fractionation Technology Revenue Market Share Comparison (2019 & 2023 & 2030)
 Figure 28. United States VS China: Blood Plasma Fractionation Technology Consumption Value Market Share Comparison (2019 & 2023 & 2030)
 Figure 29. World Blood Plasma Fractionation Technology Market Size by Type, (USD Million), 2019 & 2023 & 2030
 Figure 30. World Blood Plasma Fractionation Technology Market Size Market Share by Type in 2023
 Figure 31. Albumin
 Figure 32. Immune Globulin
 Figure 33. Coagulation Factor
 Figure 34. Others
 Figure 35. World Blood Plasma Fractionation Technology Market Size Market Share by Type (2019-2030)
 Figure 36. World Blood Plasma Fractionation Technology Market Size by Application, (USD Million), 2019 & 2023 & 2030
 Figure 37. World Blood Plasma Fractionation Technology Market Size Market Share by Application in 2023
 Figure 38. Hospital
 Figure 39. Retail Pharmacy
 Figure 40. Others
 Figure 41. World Blood Plasma Fractionation Technology Market Size Market Share by Application (2019-2030)
 Figure 42. Blood Plasma Fractionation Technology Industrial Chain
 Figure 43. Methodology
 Figure 44. Research Process and Data Source

Companies Mentioned

Takeda
CSL
Grifols
Octapharma
Kedrion
LFB Group
Biotest
BPL
RAAS
CBPO
Hualan Bio
Tiantan Bio
Shuanglin Bio
Boya Bio
Yuanda Shuyang
Weiguang Bio
Nanyue Bio
KM Biologics